Literature DB >> 1622186

In vitro activity of E1040 against imipenem-resistant Pseudomonas aeruginosa strains.

M Watanabe1, E Inoue, K Katsu, S Iyobe, S Mitsuhashi.   

Abstract

E1040 showed the most potent activity (MIC for 90% of strains, 6.25 micrograms/ml) among beta-lactams tested against 70 strains of imipenem-resistant Pseudomonas aeruginosa. Two strains showed high-level resistance to E1040; one strain produced a type II oxyiminocephalosporin-hydrolyzing beta-lactamase (group 3), and the other produced an enzyme similar to a type II penicillinase (OXA-1). Both beta-lactamases contributed to resistance to E1040.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1622186      PMCID： PMC190582          DOI： 10.1128/AAC.36.3.684

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

1.  Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

Authors:  J P Quinn; E J Dudek; C A DiVincenzo; D A Lucks; S A Lerner
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

2.  Emergence of resistance to imipenem in Pseudomonas aeruginosa.

Authors:  M J Lynch; G L Drusano; H L Mobley
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

3.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

4.  Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein.

Authors:  K H Büscher; W Cullmann; W Dick; W Opferkuch
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

5.  Molecular alteration of the 140-megadalton plasmid associated with loss of virulence and Congo red binding activity in Shigella flexneri.

Authors:  C Sasakawa; K Kamata; T Sakai; S Y Murayama; S Makino; M Yoshikawa
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

6.  Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa.

Authors:  J Trias; J Dufresne; R C Levesque; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

7.  Transferable imipenem resistance in Pseudomonas aeruginosa.

Authors:  M Watanabe; S Iyobe; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

8.  In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.

Authors:  N Watanabe; K Katsu; M Moriyama; K Kitoh
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

9.  Heterogeneity of class I beta-lactamase expression in clinical isolates of Pseudomonas aeruginosa.

Authors:  C C Sanders; M L Gates; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

10.  Interaction of E1040 with cephalosporinase from Citrobacter freundii GN7391.

Authors:  E Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.